Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRAF3IP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MZF1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPE65 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAP29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVEN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC120 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFYC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00667 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01222 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on